200 related articles for article (PubMed ID: 18065959)
1. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
[TBL] [Abstract][Full Text] [Related]
2. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
Jedrych J; McNiff JM
Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
[TBL] [Abstract][Full Text] [Related]
3. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
Sellheyer K; Nelson P; Kutzner H; Patel RM
J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma.
Evangelista MT; North JP
J Cutan Pathol; 2015 Nov; 42(11):824-31. PubMed ID: 26016446
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.
Abbas O; Richards JE; Mahalingam M
Mod Pathol; 2010 Nov; 23(11):1535-43. PubMed ID: 20711172
[TBL] [Abstract][Full Text] [Related]
7. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery.
Merritt BG; Snow SN; Longley BJ
Cutis; 2010 May; 85(5):254-8. PubMed ID: 20540416
[TBL] [Abstract][Full Text] [Related]
8. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors.
Vidal CI; Goldberg M; Burstein DE; Emanuel HJ; Emanuel PO
Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297
[TBL] [Abstract][Full Text] [Related]
9. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma?
Mohanty SK; Sardana R; McFall M; Pradhan D; Usmani A; Jha S; Mishra SK; Sampat NY; Lobo A; Wu JM; Balzer BL; Frishberg DP
Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):273-277. PubMed ID: 35384877
[TBL] [Abstract][Full Text] [Related]
10. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor.
Bartoš V
Acta Dermatovenerol Croat; 2019 Dec; 27(4):282-284. PubMed ID: 31969246
[TBL] [Abstract][Full Text] [Related]
11. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
Smith KJ; Williams J; Corbett D; Skelton H
Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
[TBL] [Abstract][Full Text] [Related]
12. Microcystic adnexal carcinoma versus desmoplastic trichoepithelioma: a comparative study.
Tse JY; Nguyen AT; Le LP; Hoang MP
Am J Dermatopathol; 2013 Feb; 35(1):50-5. PubMed ID: 22722464
[TBL] [Abstract][Full Text] [Related]
13. Collision tumor of microcystic adnexal carcinoma and squamous cell carcinoma discovered on Mohs sections.
Ken KM; Moye MS; Vandergriff T; Nijhawan RI
JAAD Case Rep; 2020 Jun; 6(6):479-481. PubMed ID: 32490104
[No Abstract] [Full Text] [Related]
14. Expression of BerEP4 and CD10 IHC Markers in Basal Cell Carcinoma, Squamous Cell Carcinoma and Adnexal Tumours of Follicular Differentiation: A Comparative Study.
Shabeer N; Nair NG; Vijayaraghavan L
Indian J Dermatol; 2023; 68(2):233. PubMed ID: 37275796
[TBL] [Abstract][Full Text] [Related]
15. [Microcystic adnexal carcinoma: A case report].
Jean-Jacques B; Michels JJ; Veyssiere A; Haidar D
Ann Pathol; 2018 Jun; 38(3):198-201. PubMed ID: 29622469
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: evaluation using tissue microarray samples.
Tebcherani AJ; de Andrade HF; Sotto MN
Mod Pathol; 2012 Oct; 25(10):1345-53. PubMed ID: 22684216
[TBL] [Abstract][Full Text] [Related]
17. Merkel cells and sclerosing epithelial neoplasms.
Abesamis-Cubillan E; El-Shabrawi-Caelen L; LeBoit PE
Am J Dermatopathol; 2000 Aug; 22(4):311-5. PubMed ID: 10949455
[TBL] [Abstract][Full Text] [Related]
18. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms.
Koga K; Anan T; Fukumoto T; Fujimoto M; Nabeshima K
Histopathology; 2020 Jan; 76(2):318-324. PubMed ID: 31429981
[TBL] [Abstract][Full Text] [Related]
19. Microcystic adnexal carcinoma with mandibular bone marrow involvement: a case report with immunohistochemistry.
Nagatsuka H; Rivera RS; Gunduz M; Siar CH; Tamamura R; Mizukawa N; Asaumi J; Nagai N
Am J Dermatopathol; 2006 Dec; 28(6):518-22. PubMed ID: 17122497
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic Trichoepithelioma With Pseudocarcinomatous Hyperplasia: A Folliculosebaceous Neoplasm in Young Persons.
Wang MZ; McNiff JM; McCalmont TH; LeBoit PE
Am J Dermatopathol; 2021 Nov; 43(11):788-793. PubMed ID: 33899770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
